Initiation and continued use of oral pre-exposure prophylaxis among pregnant and postpartum women in South Africa (PrEP-PP): a demonstration cohort study

By sjmartinez • October 31, 2024

Joseph Davey DL, Mvududu R, Mashele N, Bheemraj K, Khadka N, Johnson LF, Dean SS, Gorbach P, Bekker LG, Coates TJ, Myer L. Initiation and continued use of oral pre-exposure prophylaxis among pregnant and postpartum women in South Africa (PrEP-PP): a demonstration cohort study. Lancet HIV. 2024 Nov;11(11):e746-e755. doi: 10.1016/S2352-3018(24)00240-6. PMID: 39477557.

Tags: Infectious Diseases, Publications

Assessment of disability and disease burden in neuromyelitis optica spectrum disorders in the CIRCLES Cohort

Gholizadeh S, Exuzides A, Sinnott J, Palmer C, Waltz M, Rose JW, Jolley AM, Behne JM, Behne MK, Blaschke TF, Smith TJ, Lewis KE, Cook[...]

Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future

Adam SJ, Buchman TG, Currier JS, Draghia-Akli R, Fessel JP, Higgs ES, Hughes EA, LaVange L, Menetski JP, Read SW, Rosenberg Y, Tressler R; ACTIV[...]

ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

Keshtkar-Jahromi M, Anstrom KJ, Barkauskas C, Brown SM, Daar ES, Fischer W, Gibbs KW, Higgs ES, Hughes MD, Jagannathan P, LaVange L, Lindsell CJ, Nayak[...]